BACKGROUND: To analyze postoperative, in-hospital, complication rates in patients with organ transplantation before radical prostatectomy (RP). METHODS: From National Inpatient Sample (NIS) database (2000-2015) prostate cancer patients treated with RP were abstracted and stratified according to prior organ transplant versus nontransplant. Multivariable logistic regression models predicted in-hospital complications. RESULTS: Of all eligible 202,419 RP patients, 216 (0.1%) underwent RP after prior organ transplantation. Transplant RP patients exhibited higher proportions of Charlson comorbidity index ≥2 (13.0% vs. 3.0%), obesity (9.3% vs. 5.6%, both p < 0.05), versus to nontransplant RP. Of transplant RP patients, 96 underwent kidney (44.4%), 44 heart (20.4%), 40 liver (18.5%), 30 (13.9%) bone marrow, <11 lung (<5%), and <11 pancreatic (<5%) transplantation before RP. Within transplant RP patients, rates of lymph node dissection ranged from 37.5% (kidney transplant) to 60.0% (bone marrow transplant, p < 0.01) versus 51% in nontransplant patients. Regarding in-hospital complications, transplant patients more frequently exhibited, diabetic (31.5% vs. 11.6%, p < 0.001), major (7.9% vs. 2.9%) cardiac complications (3.2% vs. 1.2%, p = 0.01), and acute kidney failure (5.1% vs. 0.9%, p < 0.001), versus nontransplant RP. In multivariable logistic regression models, transplant RP patients were at higher risk of acute kidney failure (odds ratio [OR]: 4.83), diabetic (OR: 2.81), major (OR: 2.39), intraoperative (OR: 2.38), cardiac (OR: 2.16), transfusion (OR: 1.37), and overall complications (1.36, all p < 0.001). No in-hospital mortalities were recorded in transplant patients after RP. CONCLUSIONS: Of all transplants before RP, kidney ranks first. RP patients with prior transplantation have an increased risk of in-hospital complications. The highest risk, relative to nontransplant RP patients appears to acute kidney failure.

Cancer Prognostics and Health Outcomes Unit Division of Urology University of Montréal Health Center Montréal Canada

Department of Urology 2nd Faculty of Medicine Charles University Prag Czech Republic

Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria

Department of Urology Policlinico San Martino Hospital University of Genova Genova Italy

Department of Urology University Hospital Frankfurt Frankfurt am Main Frankfurt Germany

Department of Urology University Hospital Hamburg Eppendorf Hamburg Germany

Department of Urology University of Texas Southwestern Dallas Texas USA

Departments of Urology Weill Cornell Medical College New York New York USA

Division of Urology Department of Special Surgery Jordan University Hospital The University of Jordan Amman Jordan

Institute for Urology and Reproductive Health 1 M Sechenov 1st Moscow State Medical University Moscow Russia

Martini Klinik Prostate Cancer Center University Hospital Hamburg Eppendorf Hamburg Germany

Zobrazit více v PubMed

Mouzinuzin M, Bachaud J-M, Kamar N, et al. Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients. Transplantation. 2004;78(10):1496-1500.

Heidenreich A, Pfister D, Thissen A, Piper C, Porres D. Radical retropubic and perineal prostatectomy for clinically localised prostate cancer in renal transplant recipients. Arab J Urol. 2014;12(2):142-148.

Narváez A, Suarez J, Riera L, Castells-Esteve M, Cocera R, Vigués F. Our experience in the management of prostate cancer in renal transplant recipients. Actas Urol Esp. 2018;42(4):249-255.

Minami K, Harada H, Sasaki H, Higuchi H, Tanaka H. Robot-assisted radical prostatectomy in a second kidney transplant recipient. J Endourol Case Rep. 2020;6(4):540-543.

Marra G, Dalmasso E, Agnello M, et al. Prostate cancer treatment in renal transplant recipients: a systematic review. BJU Int. 2018;121(3):327-344.

Kleinclauss FM, Neuzillet Y, Tillou X, et al. Morbidity of retropubic radical prostatectomy for prostate cancer in renal transplant recipients: multicenter study from Renal Transplantation Committee of French Urological Association. Urology. 2008;72(6):1366-1370.

Breyer BN, Whitson JM, Freise CE, Meng MV. Prostate cancer screening and treatment in the transplant population: current status and recommendations. J Urol. 2009;181(5):2018-2025.

Hevia V, Boissier R, Rodríguez-Faba Ó, et al. Management of localised prostate cancer in kidney transplant patients: a systematic review from the EAU Guidelines on Renal Transplantation Panel. Eur Urol Focus. 2018;4(2):153-162.

Wagener N, Nyarangi-Dix JN, Teber D, Zeier M, Hohenfellner M. Applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients. Transplant Proc. 2012;44(5):1287-1292.

Beyer B, Mandel P, Michl U, et al. Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy. World J Urol. 2016;34(8):1101-1105.

Singh I, Patel BN, Thohan V, Hemal AK. Robot-assisted laparoscopic radical prostatectomy after heart transplantation. Urol Ann. 2013;5(1):56-58.

Thompson RH, Leibovich BC, Karnes RJ, Bergstralh EJ, Blute ML. Radical retropubic prostatectomy in immunosuppressed transplant recipients. J Urol. 2008;179(4):1349-1352.

Tillou X, Chiche L, Guleryuz K, Hervé S, Bensadoun H, Doerfler A. Prostate carcinoma in liver transplant recipients: think about it!. Urol Oncol. 2015;33(6):265.e9-13.

Reiter WJ, Mock K. Radical prostatectomy for localized prostate cancer in a liver transplant recipient. Urol Int. 2005;74(1):95-96.

Bayne A, Barry JM, Garzotto M. Radical retropubic prostatectomy after orthotopic liver transplantation. Urology. 2005;65(1):175.

HCUP-US NIS Overviewhttps://www.hcup-us.ahrq.gov/nisoverview.jsp; 2021.

Mazzone E, Preisser F, Nazzani S, et al. The effect of lymph node dissection in metastatic prostate cancer patients treated with radical prostatectomy: a contemporary analysis of survival and early postoperative outcomes. Eur Urol Oncol. 2019;2(5):541-548.

Yu HY, Hevelone ND, Lipsitz SR, et al. Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol. 2012;61:1239-1244.

Wenzel M, Würnschimmel C, Ruvolo CC, et al. Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores. Prostate. 2021;81(12):874-881. https://doi.org/10.1002/pros.24184

Würnschimmel C, Kachanov M, Wenzel M, et al. Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort. Prostate. 2021;81(12):849-856. https://doi.org/10.1002/pros.24181

Wenzel M, Nocera L, Collà Ruvolo C, et al. Racial/ethnic disparities in tumor characteristics and treatments in favorable and unfavorable intermediate risk prostate cancer. J Urol. 2021;206(1):69-79. https://doi.org/10.1097/JU.0000000000001695

Cigrovski Berkovic M, Virovic-Jukic L, Bilic-Curcic I, Mrzljak A. Post-transplant diabetes mellitus and preexisting liver disease-a bidirectional relationship affecting treatment and management. World J Gastroenterol. 2020;26(21):2740-2757.

Becchetti C, Dirchwolf M, Banz V, Dufour J-F. Medical management of metabolic and cardiovascular complications after liver transplantation. World J Gastroenterol. 2020;26(18):2138-2154.

Matas AJ, Vock DM. Prednisone-free maintenance immunosuppression in obese kidney transplant recipients. Clin Transplant. 2019;33(10):e13668.

Mahillo B, Carmona M, Alvarez M, et al. Worldwide distribution of solid organ transplantation and access of population to those practices. Transplantation. 2018;102:S71-S72. https://doi.org/10.1097/01.tp.0000542650.33995.b3

Fahlenkamp D, Schönberger B, Türk J, Loening SA. Experiences with laparoscopic lymphocele drainage. Urologe A. 1994;33(4):336-341.

Sun G-H, Fu Y-T, Wu C-J, Chang S-Y. Povidone-iodine instillation for management of pelvic lymphocele after pelvic lymphadenectomy for staging prostate cancer. Arch Androl. 2003;49(6):463-466.

Domagala P, van den Berg T, Tran K, et al. Surgical safety and efficacy of third kidney transplantation in the ipsilateral iliac fossa. Ann Transplant. 2019;24:132-138.

Hagen ME, Pugin F, Bucher P, Fasel J, Markar S, Morel P. Robotic kidney implantation for kidney transplantation: initial experience. J Robot Surg. 2010;4(4):271-276.